Cargando…

Cancer treatment data available in European cancer registries: Where are we and where are we going?

Population-based cancer registries are responsible for collecting incidence and survival data on all reportable neoplasms within a defined geographical area. During the last decades, the role of cancer registries has evolved beyond monitoring epidemiological indicators, as they are expanding their a...

Descripción completa

Detalles Bibliográficos
Autores principales: Giusti, Francesco, Martos, Carmen, Trama, Annalisa, Bettio, Manola, Sanvisens, Arantza, Audisio, Riccardo, Arndt, Volker, Francisci, Silvia, Dochez, Carine, Ribes, Josepa, Fernández, Laura Pareja, Gavin, Anna, Gatta, Gemma, Marcos-Gragera, Rafael, Lievens, Yolande, Allemani, Claudia, De Angelis, Roberta, Visser, Otto, Van Eycken, Liesbet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944949/
https://www.ncbi.nlm.nih.gov/pubmed/36845700
http://dx.doi.org/10.3389/fonc.2023.1109978
_version_ 1784892032478609408
author Giusti, Francesco
Martos, Carmen
Trama, Annalisa
Bettio, Manola
Sanvisens, Arantza
Audisio, Riccardo
Arndt, Volker
Francisci, Silvia
Dochez, Carine
Ribes, Josepa
Fernández, Laura Pareja
Gavin, Anna
Gatta, Gemma
Marcos-Gragera, Rafael
Lievens, Yolande
Allemani, Claudia
De Angelis, Roberta
Visser, Otto
Van Eycken, Liesbet
author_facet Giusti, Francesco
Martos, Carmen
Trama, Annalisa
Bettio, Manola
Sanvisens, Arantza
Audisio, Riccardo
Arndt, Volker
Francisci, Silvia
Dochez, Carine
Ribes, Josepa
Fernández, Laura Pareja
Gavin, Anna
Gatta, Gemma
Marcos-Gragera, Rafael
Lievens, Yolande
Allemani, Claudia
De Angelis, Roberta
Visser, Otto
Van Eycken, Liesbet
author_sort Giusti, Francesco
collection PubMed
description Population-based cancer registries are responsible for collecting incidence and survival data on all reportable neoplasms within a defined geographical area. During the last decades, the role of cancer registries has evolved beyond monitoring epidemiological indicators, as they are expanding their activities to studies on cancer aetiology, prevention, and quality of care. This expansion relies also on the collection of additional clinical data, such as stage at diagnosis and cancer treatment. While the collection of data on stage, according to international reference classification, is consolidated almost everywhere, data collection on treatment is still very heterogeneous in Europe. This article combines data from a literature review and conference proceedings together with data from 125 European cancer registries contributing to the 2015 ENCR-JRC data call to provide an overview of the status of using and reporting treatment data in population-based cancer registries. The literature review shows that there is an increase in published data on cancer treatment by population-based cancer registries over the years. In addition, the review indicates that treatment data are most often collected for breast cancer, the most frequent cancer in women in Europe, followed by colorectal, prostate and lung cancers, which are also more common. Treatment data are increasingly being reported by cancer registries, though further improvements are required to ensure their complete and harmonised collection. Sufficient financial and human resources are needed to collect and analyse treatment data. Clear registration guidelines are to be made available to increase the availability of real-world treatment data in a harmonised way across Europe.
format Online
Article
Text
id pubmed-9944949
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99449492023-02-23 Cancer treatment data available in European cancer registries: Where are we and where are we going? Giusti, Francesco Martos, Carmen Trama, Annalisa Bettio, Manola Sanvisens, Arantza Audisio, Riccardo Arndt, Volker Francisci, Silvia Dochez, Carine Ribes, Josepa Fernández, Laura Pareja Gavin, Anna Gatta, Gemma Marcos-Gragera, Rafael Lievens, Yolande Allemani, Claudia De Angelis, Roberta Visser, Otto Van Eycken, Liesbet Front Oncol Oncology Population-based cancer registries are responsible for collecting incidence and survival data on all reportable neoplasms within a defined geographical area. During the last decades, the role of cancer registries has evolved beyond monitoring epidemiological indicators, as they are expanding their activities to studies on cancer aetiology, prevention, and quality of care. This expansion relies also on the collection of additional clinical data, such as stage at diagnosis and cancer treatment. While the collection of data on stage, according to international reference classification, is consolidated almost everywhere, data collection on treatment is still very heterogeneous in Europe. This article combines data from a literature review and conference proceedings together with data from 125 European cancer registries contributing to the 2015 ENCR-JRC data call to provide an overview of the status of using and reporting treatment data in population-based cancer registries. The literature review shows that there is an increase in published data on cancer treatment by population-based cancer registries over the years. In addition, the review indicates that treatment data are most often collected for breast cancer, the most frequent cancer in women in Europe, followed by colorectal, prostate and lung cancers, which are also more common. Treatment data are increasingly being reported by cancer registries, though further improvements are required to ensure their complete and harmonised collection. Sufficient financial and human resources are needed to collect and analyse treatment data. Clear registration guidelines are to be made available to increase the availability of real-world treatment data in a harmonised way across Europe. Frontiers Media S.A. 2023-02-08 /pmc/articles/PMC9944949/ /pubmed/36845700 http://dx.doi.org/10.3389/fonc.2023.1109978 Text en Copyright © 2023 Giusti, Martos, Trama, Bettio, Sanvisens, Audisio, Arndt, Francisci, Dochez, Ribes, Fernández, Gavin, Gatta, Marcos-Gragera, Lievens, Allemani, De Angelis, Visser, Van Eycken and the ENCR Working Group on Treatment Data Harmonisation https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Giusti, Francesco
Martos, Carmen
Trama, Annalisa
Bettio, Manola
Sanvisens, Arantza
Audisio, Riccardo
Arndt, Volker
Francisci, Silvia
Dochez, Carine
Ribes, Josepa
Fernández, Laura Pareja
Gavin, Anna
Gatta, Gemma
Marcos-Gragera, Rafael
Lievens, Yolande
Allemani, Claudia
De Angelis, Roberta
Visser, Otto
Van Eycken, Liesbet
Cancer treatment data available in European cancer registries: Where are we and where are we going?
title Cancer treatment data available in European cancer registries: Where are we and where are we going?
title_full Cancer treatment data available in European cancer registries: Where are we and where are we going?
title_fullStr Cancer treatment data available in European cancer registries: Where are we and where are we going?
title_full_unstemmed Cancer treatment data available in European cancer registries: Where are we and where are we going?
title_short Cancer treatment data available in European cancer registries: Where are we and where are we going?
title_sort cancer treatment data available in european cancer registries: where are we and where are we going?
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944949/
https://www.ncbi.nlm.nih.gov/pubmed/36845700
http://dx.doi.org/10.3389/fonc.2023.1109978
work_keys_str_mv AT giustifrancesco cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing
AT martoscarmen cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing
AT tramaannalisa cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing
AT bettiomanola cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing
AT sanvisensarantza cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing
AT audisioriccardo cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing
AT arndtvolker cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing
AT franciscisilvia cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing
AT dochezcarine cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing
AT ribesjosepa cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing
AT fernandezlaurapareja cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing
AT gavinanna cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing
AT gattagemma cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing
AT marcosgragerarafael cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing
AT lievensyolande cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing
AT allemaniclaudia cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing
AT deangelisroberta cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing
AT visserotto cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing
AT vaneyckenliesbet cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing
AT cancertreatmentdataavailableineuropeancancerregistrieswhereareweandwherearewegoing